A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects
A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® Perimembranous Ventricular Septal Defect (PmVSD) Occluder in Patients With Perimembranous Ventricular Septal Defects
Sponsor: Occlutech International AB
Listed as NCT04034498, this observational or N/A phase trial focuses on Perimembranous Ventricular Septal Defect and remains ongoing. Sponsored by Occlutech International AB, it has been updated 9 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting
-
Sep 2024 — Feb 2026 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Mar 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Dec 2020 [monthly]
Recruiting
-
Apr 2020 — Jul 2020 [monthly]
Recruiting
-
Aug 2019 — Apr 2020 [monthly]
Recruiting
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Occlutech International AB
For direct contact, visit the study record on ClinicalTrials.gov .